BIOLASE (NASDAQ:BIOL) Lifted to “Hold” at StockNews.com

StockNews.com upgraded shares of BIOLASE (NASDAQ:BIOL – Free Report) from a sell rating to a hold rating in a research report released on Monday. Separately, Benchmark decreased their target price on shares of BIOLASE from $10.00 to $4.00 in a report on Wednesday, September 20th. View Our Latest Analysis on BIOLASE BIOLASE Trading Down 1.8 […]

Leave a Reply

Your email address will not be published.

Previous post Greif (NYSE:GEF) Upgraded to Buy by StockNews.com
Next post Johnson & Johnson (NYSE:JNJ) Rating Lowered to Buy at StockNews.com